Enhancing the efficacy of Pseudomonas entomophila 23S, a PGPR for biocontrol of bacterial canker disease in tomato ******

增强嗜虫假单胞菌 23S(一种用于生物防治番茄细菌性溃疡病的 PGPR)的功效 ******

基本信息

  • 批准号:
    534001-2018
  • 负责人:
  • 金额:
    $ 1.82万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Engage Grants Program
  • 财政年份:
    2018
  • 资助国家:
    加拿大
  • 起止时间:
    2018-01-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

Bacterial canker disease, caused by Clavibacter michiganensis subsp. michiganensis (Cmm) is one of the most serious diseases of tomato. The disease has caused substantial crop losses and become a serious concern for both field and greenhouse tomato production in many parts of the world, including Canada. Existing control strategies, such as seed treatment and chemical control, have shown only limited efficacy in controlling this disease. Thus, effective control strategies are urgently required. The Smith laboratory at McGill University has discovered several strains that show antagonistic activity against Cmm, and an anti-Cmm compound produced by one of these strains, Pseudomonas sp. 23S was isolated. Given the seriousness of the disease damages, this anti-Cmm compound, as well as the producing stain is great potential as a new effective control strategy for tomato bacterial canker. Lallemand has been interested in developing a product to control Cmm and has been looking for potential approaches. With Lallemand's expertise on strain production, scale-up, formulation and product development, success in the proposed work would allow a full effort to completely understand the potential of a technology based on Pseudomonas sp. 23S and eventual full deployment in the Canadian context. We propose to study the anti- Cmm compounds produced by Pseudomonas sp. 23S and to determine the best production method. The project will consist of elucidating the minimum inhibitory concentration of the anti-Cmm compound, studying the concentration of the compound during various incubation phases, and examining the effects of Cmm on the production of anti- Cmm compounds produced by Pseudomonas sp. 23S. This work will improve the sustainability and economics of Canadian tomato producers and give them further leadership in the North American tomato production market. The work will provide a deeper understanding of the newly discovered anti-Cmm compound produced by Pseudomonas sp. 23S and its best production method, leading to a broader collaboration between Lallemand and McGill University; one that will allow further utilization of biologicals and the development of new products in agriculture.
细菌性溃疡病,由密歇根棒状杆菌亚种引起。密歇根病(Cmm)是番茄最严重的病害之一。该疾病已造成大量农作物损失,并成为包括加拿大在内的世界许多地区田间和温室番茄生产的严重问题。现有的控制策略,例如种子处理和化学控制,在控制这种疾病方面效果有限。因此,迫切需要有效的控制策略。麦吉尔大学史密斯实验室发现了几种对 Cmm 显示拮抗活性的菌株,以及其中一种菌株假单胞菌产生的抗 Cmm 化合物。 23S被隔离。考虑到该病害的严重性,这种抗 Cmm 化合物以及产生的染色剂具有作为番茄细菌性溃疡病新的有效控制策略的巨大潜力。 Lallemand 一直对开发控制 Cmm 的产品感兴趣,并一直在寻找潜在的方法。凭借拉勒曼在菌株生产、放大、配方和产品开发方面的专业知识,拟议工作的成功将有助于充分了解基于假单胞菌的技术的潜力。 23S 并最终在加拿大全面部署。我们建议研究假单胞菌产生的抗 Cmm 化合物。 23S并确定最佳生产方法。该项目将包括阐明抗 Cmm 化合物的最低抑制浓度、研究该化合物在不同培养阶段的浓度以及检查 Cmm 对假单胞菌产生的抗 Cmm 化合物的影响。 23S。这项工作将提高加拿大番茄生产商的可持续性和经济效益,并使他们在北美番茄生产市场上进一步处于领先地位。这项工作将使人们更深入地了解新发现的由假单胞菌产生的抗 Cmm 化合物。 23S 及其最佳生产方法,促成拉勒曼德大学和麦吉尔大学之间更广泛的合作;它将允许进一​​步利用生物制品和开发农业新产品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Smith, Donald其他文献

Barriers associated with exercise and community access for individuals with stroke
Supplementation with solutions of lipo-chitooligosacharide Nod Bj V (C18:1, MeFuc) and thuricin 17 regulates leaf arrangement, biomass, and root development of canola (Brassica napus [L.])
  • DOI:
    10.1007/s10725-015-0072-8
  • 发表时间:
    2016-01-01
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Schwinghamer, Timothy;Souleimanov, Alfred;Smith, Donald
  • 通讯作者:
    Smith, Donald
Biomarkers of Mn exposure in humans
  • DOI:
    10.1002/ajim.20506
  • 发表时间:
    2007-11-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Smith, Donald;Gwiazda, Roberto;Lucchini, Roberto
  • 通讯作者:
    Lucchini, Roberto
Biomarkers of manganese exposure in pregnant women and children living in an agricultural community in California.
  • DOI:
    10.1021/es503866a
  • 发表时间:
    2014-12-16
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    Gunier, Robert B.;Maria Mora, Ana;Smith, Donald;Arora, Manish;Austin, Christine;Eskenazi, Brenda;Bradman, Asa
  • 通讯作者:
    Bradman, Asa
The effect of vitamin K insufficiency on histological and structural properties of knee joints in aging mice.
  • DOI:
    10.1016/j.ocarto.2020.100078
  • 发表时间:
    2020-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shea, M Kyla;Booth, Sarah L;Harshman, Stephanie G;Smith, Donald;Carlson, Cathy S;Harper, Lindsey;Armstrong, Alexandra R;Fang, Min;Cancela, M Leonor;Marcio Simao;Loeser, Richard F
  • 通讯作者:
    Loeser, Richard F

Smith, Donald的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Smith, Donald', 18)}}的其他基金

Plant-microbe interactions: Understanding the signal loop for improved plant productivity
植物-微生物相互作用:了解信号回路以提高植物生产力
  • 批准号:
    RGPIN-2020-07047
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Microbial consortia for enhanced and sustainable cannabis production
用于增强和可持续大麻生产的微生物联盟
  • 批准号:
    557075-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Alliance Grants
Plant-microbe interactions: Understanding the signal loop for improved plant productivity
植物-微生物相互作用:了解信号回路以提高植物生产力
  • 批准号:
    RGPIN-2020-07047
  • 财政年份:
    2021
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Enhanced yield and cannabinoid production of homogenous medical marijuana plants
提高同质医用大麻植物的产量和大麻素产量
  • 批准号:
    517552-2017
  • 财政年份:
    2020
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Collaborative Research and Development Grants
Microbial consortia for enhanced and sustainable cannabis production
用于增强和可持续大麻生产的微生物联盟
  • 批准号:
    557075-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Alliance Grants
Development of better biologicals as a more sustainable approach to Canadian agriculture
开发更好的生物制品作为加拿大农业更可持续的方法
  • 批准号:
    513505-2017
  • 财政年份:
    2020
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Collaborative Research and Development Grants
Plant-microbe interactions: Understanding the signal loop for improved plant productivity
植物-微生物相互作用:了解信号回路以提高植物生产力
  • 批准号:
    RGPIN-2020-07047
  • 财政年份:
    2020
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Stress specific signalling between microbes and plants
微生物和植物之间的应激特异性信号传导
  • 批准号:
    RGPIN-2015-06328
  • 财政年份:
    2019
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Marine plant derivatives to enhance crop plants
海洋植物衍生物增强农作物
  • 批准号:
    543586-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Collaborative Research and Development Grants
Enhanced yield and cannabinoid production of homogenous medical marijuana plants
提高同质医用大麻植物的产量和大麻素产量
  • 批准号:
    517552-2017
  • 财政年份:
    2019
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Collaborative Research and Development Grants

相似国自然基金

噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目

相似海外基金

Regulation of the virulence factor PlcH in Pseudomonas aeruginosa
铜绿假单胞菌毒力因子PlcH的调控
  • 批准号:
    10884588
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Pyocins as antibacterials to treat Pseudomonas aeruginosa infections
脓毒素作为抗菌药物治疗铜绿假单胞菌感染
  • 批准号:
    10727705
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Novel Antibiofilm Treatments for Pseudomonas aeruginosa Infection
治疗铜绿假单胞菌感染的新型抗菌膜疗法
  • 批准号:
    10648172
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
A Novel Mucosal Vaccine for Pseudomonas aeruginosa Infection
一种针对铜绿假单胞菌感染的新型粘膜疫苗
  • 批准号:
    10446501
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Formulation of a prophylactic vaccine against Pseudomonas aeruginosa
铜绿假单胞菌预防性疫苗的配制
  • 批准号:
    10592374
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
A NOVEL THERAPEUTIC WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY
一种具有泛抗性假单胞菌和伯克霍尔德氏菌活性的新型治疗药物
  • 批准号:
    10710591
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa
预防铜绿假单胞菌定植的预防性疫苗
  • 批准号:
    10582221
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
A Novel Mucosal Vaccine for Pseudomonas aeruginosa Infection
一种针对铜绿假单胞菌感染的新型粘膜疫苗
  • 批准号:
    10550157
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Type 3 secretion system inhibitors to treat Pseudomonas aeruginosa keratitis
3型分泌系统抑制剂治疗铜绿假单胞菌角膜炎
  • 批准号:
    10484345
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
Formulation of a prophylactic vaccine against Pseudomonas aeruginosa
铜绿假单胞菌预防性疫苗的配制
  • 批准号:
    10481409
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了